Relapse of intracranial germinoma 23 years postirradiation in a patient given growth hormone replacement.
Affiliation
Department of Clinical Oncology, Christie Hospital NHS Trust, Manchester, United Kingdom.Issue Date
1997-07
Metadata
Show full item recordAbstract
There is no clear evidence that growth hormone replacement therapy for treatment-related growth hormone deficiency in patients with childhood intracranial malignancies has a role in tumour relapse or second malignancy. A 16-year-old girl with an intracranial germinoma was treated with local radiotherapy and subsequently received growth hormone replacement therapy as an adult. Three years after starting growth hormone therapy, 23 years after her radiotherapy treatment, the patient's tumour recurred. Surveillance requirements for patients receiving growth hormone in this setting are discussed.Citation
Relapse of intracranial germinoma 23 years postirradiation in a patient given growth hormone replacement. 1997, 29 (1):41-4 Med. Pediatr. Oncol.Journal
Medical and Pediatric OncologyDOI
10.1002/(SICI)1096-911X(199707)29:1<41::AID-MPO8>3.0.CO;2-SPubMed ID
9142205Type
ArticleLanguage
enISSN
0098-1532ae974a485f413a2113503eed53cd6c53
10.1002/(SICI)1096-911X(199707)29:1<41::AID-MPO8>3.0.CO;2-S